Kiesselbach plexus is an intricate network of veins and arteries located in the anterior part of the head and neck region. It is also known as the anterior facial artery-vein complex, and is located in the area of the nose and the upper lip. The plexus is named after German anatomist and physician Hermann Kiesselbach, who first identified and described it in 1875. The Kiesselbach plexus is an important structure in the human body, as it supplies oxygenated blood to the face and neck region. It is also involved in the drainage of deoxygenated blood from the face and neck area. The plexus is composed of four main arteries and veins: the angular artery, the facial artery, the superior labial artery, and the anterior ethmoidal artery. These four vessels form a complex network of veins and arteries that can be difficult to visualize and understand.
The Kiesselbach plexus is composed of four main arteries and veins: the angular artery, the facial artery, the superior labial artery, and the anterior ethmoidal artery. The angular artery is a branch of the external carotid artery and is located on the medial side of the nose. It runs along the lower border of the orbit and enters the plexus at the anterior part of the nose. The facial artery is a branch of the external carotid artery and is located on the lateral side of the nose. It runs along the lower border of the orbit and enters the plexus at the anterior part of the nose. The superior labial artery is a branch of the facial artery and is located on the lateral side of the nose. It runs along the upper border of the orbit and enters the plexus at the anterior part of the nose. The anterior ethmoidal artery is a branch of the ophthalmic artery and is located on the medial side of the nose. It runs along the medial wall of the orbit and enters the plexus at the anterior part of the nose.
The Kiesselbach plexus is an important structure in the human body, as it supplies oxygenated blood to the face and neck region. It is also involved in the drainage of deoxygenated blood from the face and neck area. The plexus is a common site of nosebleeds and epistaxis, which can be caused by trauma, infection, or underlying medical conditions. The Kiesselbach plexus is also an important structure for facial plastic surgery. It is commonly used as a donor site for flaps and grafts in reconstructive surgery. The vessels in the plexus are often used to provide blood supply to the facial tissues.
The diagnosis of Kiesselbach plexus disorders is based on a patient’s medical history, physical examination, and imaging studies. Imaging studies such as computed tomography (CT) and magnetic resonance imaging (MRI) can be used to visualize the plexus and to identify any abnormalities. Treatment for Kiesselbach plexus disorders depends on the underlying cause. In cases of trauma or infection, treatment may include antibiotics, antifungal medications, or surgical repair. In cases of underlying medical conditions, treatment may include medications, lifestyle modifications, or surgery.
Kiesselbach plexus is an intricate network of veins and arteries located in the anterior part of the head and neck region. It is an important structure in the human body, as it supplies oxygenated blood to the face and neck region and is involved in the drainage of deoxygenated blood from the face and neck area. The plexus is a common site of nosebleeds and epistaxis, and is also an important structure for facial plastic surgery. Diagnosis and treatment of Kiesselbach plexus disorders depends on the underlying cause and can include antibiotics, antifungal medications, lifestyle modifications, or surgery. Understanding the anatomy and clinical significance of the Kiesselbach plexus is important for doctors in order to diagnose and treat disorders of this structure.
1.
findings from the measurement of disability weights in China with an emphasis on the impact of disease burden.
2.
Maintenance Rituximab Improves Survival in Elderly MRD-Negative MCL Patients.
3.
Understudied mental health challenges among caregivers of cancer patients: A call for targeted support
4.
A Texas study found that the majority of pancreatic cancer patients do not receive life-saving surgery.
5.
According to a study, taking part in a clinical trial for cancer may not actually increase survival.
1.
A New Hope: How Procarbazine is Revolutionizing Cancer Treatment
2.
Oncology Treatment: Innovations, Education, and Clinical Practice Insights
3.
Hypogammaglobulinemia: A Comprehensive Guide for Patients and Caregivers
4.
Unleashing the Power of Immune Triads: A Novel Approach to Cancer Immunotherapy
5.
The Importance of Early Detection in Angiosarcoma: A Story of Survival
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
2.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
3.
Exploring the Hospitalization Burden in Refractory and Relapsed ALL
4.
Understanding the Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- PALOMA 2 Study.
5.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation